46 By 2021, semaglutide (Wegovy , Novo Nordisk) administered by subcutaneous injection was also approved by the US FDA as an obesity treatment (Table 1)
These are also good starting points for humans
The ESI-MS investigations were conducted in both negative and positive scanning mode enabling detection of both positively and negatively charged GSH and GSSG species, as well as (modified) iron(II) and iron(III) complexes
Treatment approaches in patients included gross-total resection (GTR) in 17 cases (73.91%), and subtotal resection in 5 cases (22.73%), while one refused the treatment
FDA approval Both medications are approved by the U.S
Below is a scientifically based overview of their research findings, mechanisms of action, and clinical potential with PubMed references for credibility